Published peptide research references
Zilucoplan
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.
DOI: 10.1007/s00415-025-13113-0
Source identity and connection checked by Codex (AI).
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy.
Source identity and connection checked by Codex (AI).
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
DOI: 10.1016/s1474-4422(23)00080-7
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Howard JF Jr
- Bresch S
- Genge A
- Hewamadduma C
- Hinton J
- Hussain Y
- Juntas-Morales R
- Kaminski HJ
- Maniaol A
- Mantegazza R
- Masuda M
- Sivakumar K
- Śmiłowski M
- Utsugisawa K
- Vu T
- Weiss MD
- Zajda M
- Boroojerdi B
- Brock M
- de la Borderie G
- Duda PW
- Lowcock R
- Vanderkelen M
- Leite MI
- RAISE Study Team
- Freimer M
- Grimson F
- Savic N
- RAISE-XT study team
- Ramdas S
- Painho T
- Vanegas MI
- Famili DT
- Lim MJ
- Jungbluth H
- Versino F
- Fattizzo B